Q1 Earnings Beat Sparks Rally: UnitedHealth Group delivered first-quarter results that exceeded Wall Street expectations, posting revenue of $111.7 billion against forecasts of $109.6 billion and adjusted earnings per share of $7.23 versus $6.57 anticipated. The firm raised its full-year EPS guidance to over $18.25, fueling a pre-market surge of more than 7 percent amid lively social media discourse.
Medicare Payment Hike Fuels Optimism: Earlier in April, a Centers for Medicare & Medicaid Services decision to increase private insurer payments by 2.5 percent propelled shares up over 11 percent, drawing praise on social media for bolstering the company's outlook. Participants highlighted the stock's rebound from recent lows, emphasizing robust cash flows and a compelling valuation relative to revenue generation.
Recovery Narrative Gains Traction: Social media conversations underscore improved medical care ratios at 83.9 percent and a $2 billion buyback authorization as signs of stabilization. While risks like Medicare headwinds persist, the prevailing view celebrates the company's resilience and potential for further upside.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Revenue
UnitedHealth Group had revenues of $111.7B in Q1 2026. This is an increase of 1.96% from the same period in the prior year.
You can track UNH financials on Quiver Quantitative's UNH stock page.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 14 times in the past 6 months. Of those trades, 7 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/19, 11/05 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $65,000 on 03/13, 12/19 and 2 sales worth up to $65,000 on 02/10, 11/12.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
- REPRESENTATIVE KEVIN HERN sold up to $500,000 on 12/23.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
UnitedHealth Group Hedge Fund Activity
We have seen 1,264 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,807 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 20,260,160 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $6,688,081,417
- CAPITAL RESEARCH GLOBAL INVESTORS removed 6,780,251 shares (-52.0%) from their portfolio in Q4 2025, for an estimated $2,238,228,657
- CARDANO RISK MANAGEMENT B.V. removed 2,264,606 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $608,839,323
- CITADEL ADVISORS LLC added 2,079,416 shares (+244.9%) to their portfolio in Q4 2025, for an estimated $686,436,015
- UBS GROUP AG removed 1,839,868 shares (-40.3%) from their portfolio in Q4 2025, for an estimated $607,358,825
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 1,568,099 shares (+532.9%) to their portfolio in Q4 2025, for an estimated $517,645,160
- AMUNDI added 1,544,066 shares (+26.6%) to their portfolio in Q4 2025, for an estimated $509,711,627
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
UnitedHealth Group Government Contracts
We have seen $16,780,453,248 of award payments to $UNH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
- EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
- EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
- EXPRESS REPORT: R3 FY25 2ND QTR FEBRUARY: $730,504,137
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
UnitedHealth Group Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/02/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/28/2026
- Leerink Partners issued a "Outperform" rating on 01/28/2026
- Bernstein issued a "Outperform" rating on 10/30/2025
To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 20 analysts offer price targets for $UNH in the last 6 months, with a median target of $396.0.
Here are some recent targets:
- Ryan Langston from TD Cowen set a target price of $337.0 on 04/23/2026
- Michael Wiederhorn from Oppenheimer set a target price of $405.0 on 04/22/2026
- Whit Mayo from Leerink Partners set a target price of $400.0 on 04/22/2026
- Ben Hendrix from RBC Capital set a target price of $400.0 on 04/22/2026
- Stephen Baxter from Wells Fargo set a target price of $397.0 on 04/22/2026
- David Toung from Argus Research set a target price of $400.0 on 04/22/2026
- Erin Wright from Morgan Stanley set a target price of $395.0 on 04/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
